Murine norovirus increases atherosclerotic lesion size and macrophages in Ldlr -/- mice

Comparative Medicine

Volumn 61, Issue 4, 2011, Pages 330-338

  Paik, Jisun ^a   Fierce, Yvette ^a   Mai, Phuong Oanh ^a   Phelps, Susan R ^a   McDonald, Thomas ^a   Treuting, Piper ^a   Drivdahl, Rolf ^a   Brabb, Thea ^a   LeBoeuf, Renee ^a   O'Brien, Kevin D ^a   Maggio Price, Lillian ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SINUS; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETIC OBESITY; DIABETOGENESIS; DIET; DISEASE MODEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INOCULATION; INSULIN SENSITIVITY; LESIONS AND DEFECTS; LIPID DIET; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; NOROVIRUS; PHENOTYPE; WEIGHT CHANGE; WEIGHT GAIN;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, LABORATORY; ATHEROSCLEROSIS; BLOOD GLUCOSE; BODY WEIGHT; CALICIVIRIDAE INFECTIONS; DIET, HIGH-FAT; HISTOLOGICAL TECHNIQUES; INSULIN RESISTANCE; MALE; MICE; MICE, KNOCKOUT; NOROVIRUS; RECEPTORS, LDL; RODENT DISEASES; UNITED STATES;

EID: 84855370476     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ayada K, Yokota K, Hirai K, Fujimoto K, Kobayashi K, Ogawa H, Hatanaka K, Hirohata S, Yoshino T, Shoenfeld Y, Matsuura E, Oguma K. 2009. Regulation of cellular immunity prevents Helicobacter pylori-induced atherosclerosis. Lupus 18:1154-1168.
2. Breslow JL. 1996. Mouse models of atherosclerosis. Science 272:685-688. (Pubitemid 26000273)
3. Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G, Viney JL, Maggio-Price L. 2001. Helicobacter-induced inflammatory bowel disease in IL10- and T-cell-deficient mice. Am J Physiol Gastrointest Liver Physiol 281:G764-G778.
4. Chira EC, McMillen TS, Wang S, Haw A 3rd, O'Brien KD, Wight TN, Chait A. 2007. Tesaglitazar, a dual peroxisome proliferatoractivated receptor αγ agonist, reduces atherosclerosis in female low-density lipoprotein receptor-deficient mice. Atherosclerosis 195:100-109. (Pubitemid 47561950)
5. Cox C, Cao S, Lu Y. 2009. Enhanced detection and study of murine norovirus 1 using a more efficient microglial cell line. Virol J 6:196.
6. Farrugia PM, Lucariello R, Coppola JT. 2009. Human immunodeficiency virus and atherosclerosis. Cardiology 17:211-215.
7. Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509.
8. Haidari M, Wyde PR, Litovsky S, Vela D, Ali M, Casscells SW, Madjid M. 2010. Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice. Atherosclerosis 208:90-96.
9. Hansson GK, Libby P. 2006. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6:508-519. (Pubitemid 43980523)
10. Henderson KS. 2008. Murine norovirus, a recently discovered and highly prevalent viral agent of mice. Lab Anim (NY) 37:314-320. (Pubitemid 351873459)
11. Hsu CC, Riley LK, Wills HM, Livingston RS. 2006. Persistent infection with and serologic cross-reactivity of 3 novel murine noroviruses. Comp Med 56:247-251. (Pubitemid 44299965)
12. Hsu CC, Wobus CE, Steffen EK, Riley LK, Livingston RS. 2005. Development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase PCR assay to detect murine norovirus 1 infection in mice. Clin Diagn Lab Immunol 12:1145-1151. (Pubitemid 41475821)
13. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. 1993. Hypercholesterolemia in low-density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92:883-893. (Pubitemid 23262411)
14. Karst SM, Wobus CE, Lay M, Davidson J. 2003. Virgin HWt. 2003. STAT1-dependent innate immunity to a Norwalk-like virus. Science 299:1575-1578. (Pubitemid 36297707)
15. Kern JM, Maass V, Maass M. 2009. Chlamydia pneumoniae adversely modulates vascular cell properties by direct interaction with signalling cascades. Thromb Haemost 102:1064-1070.
16. Kim M, Lee H, Chang KO, Ko G. 2010. Molecular characterization of murine norovirus isolates from South Korea. Virus Res 147:1-6.
17. Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC. 1998. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 128:954-959. (Pubitemid 28280193)
18. Lencioni KC, Seamons A, Treuting PM, Maggio-Price L, Brabb T. 2008. Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease. Comp Med 58:522-533.
19. Lumeng CN, Bodzin JL, Saltiel AR. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest117:175-184. (Pubitemid 46048464)
20. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. 2007. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56:16-23.
21. Muller B, Klemm U, Mas Marques A, Schreier E. 2007. Genetic diversity and recombination of murine noroviruses in immunocompromised mice. Arch Virol 152:1709-1719. (Pubitemid 47319269)
22. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD, Lobb R, Alpers CE. 1993. Vascular cell adhesion molecule 1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92:945-951. (Pubitemid 23262418)
23. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. 1996. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 16:523-532. (Pubitemid 26107723)
24. Paik J, Fierce Y, Drivdahl R, Treuting PM, Seamons A, Brabb T, Maggio-Price L. 2010. Effects of murine norovirus infection on a mouse model of diet-induced obesity and insulin resistance. Comp Med 60:189-195.
25. Perdue KA, Green KY, Copeland M, Barron E, Mandel M, Faucette LJ, Williams EM, Sosnovtsev SV, Elkins WR, Ward JM. 2007. Naturally occurring murine norovirus infection in a large research institution. J Am Assoc Lab Anim Sci 46:39-45. (Pubitemid 351182141)
26. Perry JW, Wobus CE. 2010. Endocytosis of murine norovirus 1 into murine macrophages is dependent on dynamin II and cholesterol. J Virol 84:6163-6176.
27. Ward JM, Wobus CE, Thackray LB, Erexson CR, Faucette LJ, Belliot G, Barron EL, Sosnovtsev SV, Green KY. 2006. Pathology of immunodeficient mice with naturally occurring murine norovirus infection. Toxicol Pathol 34:708-715. (Pubitemid 44665523)
28. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW Jr. 2006. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116:115-124. (Pubitemid 43121796)
29. Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, Belliot G, Krug A, Mackenzie JM, Green KY, Virgin HW. 2004. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol 2:e432.
30. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830. (Pubitemid 38063705)
31. Yan ZQ, Hansson GK. 2007. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 219:187-203. (Pubitemid 47390007)
32. Yeom SC, Yu SA, Choi EY, Lee BC, Lee WJ. 2009. Prevalence of Helicobacter hepaticus, murine norovirus, and Pneumocystis carinii and eradication efficacy of cross-fostering in genetically engineered mice. Exp Anim 58:497-504.